LCQ LCQ in Specific Patient Populations 2 — Questions and Answers
Question 1: How does LCQ performance differ in patients with neurogenic cough compared to other chronic cough etiologies?
- LCQ scores are similarly reduced, reflecting the severe QoL burden of neurogenic cough (Correct answer)
- LCQ scores are consistently higher in neurogenic cough
- Neurogenic cough does not affect LCQ social domain
- LCQ cannot detect neurogenic cough impacts
Correct answer: LCQ scores are similarly reduced, reflecting the severe QoL burden of neurogenic cough
Patients with neurogenic (hypersensitivity) cough demonstrate similarly reduced LCQ scores as other chronic cough patients, reflecting equivalent quality of life burden.
Question 2: In interstitial lung disease (ILD) patients with chronic cough, which LCQ domain tends to show the greatest impairment?
- Physical (Correct answer)
- Psychological
- Social
- All three are equally impaired
Correct answer: Physical
In ILD patients with chronic cough, the physical domain tends to show the greatest impairment due to coexisting breathlessness, fatigue, and exercise limitation.
Question 3: Can the LCQ be used to assess chronic cough in patients with lung cancer?
- Yes — it has been applied in oncology settings to measure cough-related QoL (Correct answer)
- No — cancer patients require oncology-specific tools only
- Only in early-stage cancer
- Only postoperatively
Correct answer: Yes — it has been applied in oncology settings to measure cough-related QoL
The LCQ has been used in oncology settings to evaluate cough-related quality of life in lung cancer patients as a patient-reported outcome measure.
Question 4: What challenge arises when using the LCQ in elderly patients with multiple comorbidities?
- Difficulty attributing QoL impairment to cough alone versus other conditions (Correct answer)
- The LCQ is too long for elderly patients
- Elderly patients cannot use Likert scales
- The 2-week recall period is too short for elderly patients
Correct answer: Difficulty attributing QoL impairment to cough alone versus other conditions
In elderly patients with multiple comorbidities, it can be difficult to determine whether LCQ score reductions are attributable to cough alone or confounded by other health conditions.
Question 5: Has the LCQ been validated in non-English-speaking US patient populations?
- Yes — translations in multiple languages have been validated (Correct answer)
- No — only the English version is valid in the US
- Only in Spanish
- Only in Mandarin Chinese
Correct answer: Yes — translations in multiple languages have been validated
Validated translations of the LCQ exist in multiple languages including Spanish, which is particularly relevant for the diverse US patient population.
Question 6: In patients with chronic cough receiving speech pathology treatment (cough suppression therapy), what LCQ changes are expected?
- Improved (higher) LCQ scores reflecting better QoL post-therapy (Correct answer)
- No change in LCQ scores with speech therapy
- Worsened LCQ scores initially
- LCQ is not sensitive to speech therapy outcomes
Correct answer: Improved (higher) LCQ scores reflecting better QoL post-therapy
Studies of cough suppression therapy delivered by speech pathologists have demonstrated improved LCQ scores, validating the tool's responsiveness to this treatment approach.
LCQ LCQ in Specific Patient Populations 2
How does LCQ performance differ in patients with neurogenic cough compared to other chronic cough etiologies?